Current status: 864 hESC lines, 3498 hiPSC lines, and 110 clinical studies, and 455 certificates
Monthly statistic from Feb 1, 2023
Posted on February 1, 2023
| total lines | 4362 |
| hESC lines | 864 |
| hiPSC lines | 3498 |
| derivation countries | 45 |
| projects | 258 |
| providers | 783 |
| clinical studies | 110 |
| subclones | 1946 |
| certificates | 455 |
| cell line certificates | 324 |
| project certificates | 131 |